🚀 VC round data is live in beta, check it out!

Salus Valuation Multiples

Discover revenue and EBITDA valuation multiples for Salus and similar public comparables like Gerresheimer, Arjo, Embecta, Paul Hartmann and more.

Salus Overview

About Salus

Salus is a Slovenia-based company engaged in the wholesale and distribution of medical products. It offers medicines, medical devices, medical supplies, dietary supplements, cosmetics to hospitals, pharmacies, and other customers.


Founded

1969

HQ

Slovenia

Employees

413

Website

salus.si

Financials (FY)

Revenue: $812M
EBITDA: $36M

EV

$646M

Valuation Multiples

Multiples.vc

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Salus Financials

Salus reported last fiscal year revenue of $812M and EBITDA of $36M.

In the same fiscal year, Salus generated $97M in gross profit, $36M in EBITDA, and $19M in net income.


Salus P&L

In the most recent fiscal year, Salus reported revenue of $812M and EBITDA of $36M.

Salus expects next 12-month revenue of XXX and NTM EBITDA of XXX

See Salus forward-looking valuation multiples
LTMNTMLast FYFY 2026FY 2027FY 2028
RevenueXXX$812MXXXXXXXXX
Gross ProfitXXX$97MXXXXXXXXX
Gross MarginXXX12%XXXXXXXXX
EBITDAXXX$36MXXXXXXXXX
EBITDA MarginXXX4%XXXXXXXXX
EBIT MarginXXX3%XXXXXXXXX
Net ProfitXXX$19MXXXXXXXXX
Net MarginXXX2%XXXXXXXXX
Net Debt$1MXXXXXXXXX

Financial data powered by Morningstar, Inc.

Salus Stock Performance

Salus has current market cap of $632M, and enterprise value of $646M.

Market Cap Evolution


Salus' stock price is $76.95.

See Salus trading valuation data
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$646M$632M0.5%XXXXXXXXX$2.37

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Salus Valuation Multiples

Salus trades at 0.8x EV/Revenue multiple, and 18.2x EV/EBITDA.

See valuation multiples for Salus and 15K+ public comps

Salus Financial Valuation Multiples

As of April 11, 2026, Salus has market cap of $632M and EV of $646M.

Equity research analysts estimate Salus' 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Salus has a P/E ratio of 32.5x.

LTMNTMLast FYFY 2026FY 2027FY 2028
Market cap (current)$632MXXX$632MXXXXXXXXX
EV (current)$646MXXX$646MXXXXXXXXX
EV/RevenueXXX0.8xXXXXXXXXX
EV/EBITDAXXX18.2xXXXXXXXXX
EV/EBITXXX28.2xXXXXXXXXX
EV/Gross ProfitXXX6.7xXXXXXXXXX
P/EXXX32.5xXXXXXXXXX
EV/FCFXXX44.0xXXXXXXXXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Salus Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Salus Margins & Growth Rates

Salus' revenue in the last fiscal year grew by 7%.

Salus' revenue per employee in the last FY averaged $2.0M, while opex per employee averaged $0.2M for the same period.

See operational valuation multiples for Salus and other 15K+ public comps

Salus Operational Valuation Multiples

LTMNTMLast FYFY 2026FY 2027FY 2028
Revenue GrowthXXX7%XXXXXXXXX
EBITDA MarginXXX4%XXXXXXXXX
EBITDA GrowthXXX19%XXXXXXXXX
Revenue per EmployeeXXX$2.0MXXXXXXXXX
Opex per EmployeeXXX$0.2MXXXXXXXXX
S&M Expenses to RevenueXXX6%XXXXXXXXX
G&A Expenses to RevenueXXX3%XXXXXXXXX
Opex to RevenueXXX9%XXXXXXXXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Salus Public Comps

See public comps and valuation multiples for other Medical Supplies comps.

EV/RevenueEV/EBITDA
LTM2026E2027ELTM2026E2027E
GerresheimerXXXXXXXXXXXXXXXXXX
ArjoXXXXXXXXXXXXXXXXXX
EmbectaXXXXXXXXXXXXXXXXXX
Paul HartmannXXXXXXXXXXXXXXXXXX
CerusXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXXXXXXX

Valuation data powered by FactSet, Inc.

Salus M&A Activity

Salus acquired XXX companies to date.

Last acquisition by Salus was on XXXXXXXX, XXXXX. Salus acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).

See M&A valuation multiples

Latest Acquisitions by Salus

Acquired CompanyValuationEV/RevenueEV/EBITDA
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.

Start Free Trial

Salus Investment Activity

Salus invested in XXX companies to date.

Salus made its latest investment on XXXXXXXX, XXXXX. Salus invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).

See VC round multiples

Latest Investments by Salus

CompanyValuationEV/RevenueEV/EBITDA
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Salus

When was Salus founded?Salus was founded in 1969.
Where is Salus headquartered?Salus is headquartered in Slovenia.
How many employees does Salus have?As of today, Salus has over 413 employees.
Is Salus publicly listed?Yes, Salus is a public company listed on Ljubljana Stock Exchange.
What is the stock symbol of Salus?Salus trades under SALR ticker.
When did Salus go public?Salus went public in 1999.
Who are competitors of Salus?Salus main competitors are Gerresheimer, Arjo, Embecta, Paul Hartmann.
What is the current market cap of Salus?Salus' current market cap is $632M.
What is the current revenue of Salus?Salus' last fiscal year revenue is $812M.
What is the current EV/Revenue multiple of Salus?Current revenue multiple of Salus is 0.8x.
Is Salus profitable?No, Salus is not profitable.

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial